{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:37:21Z","timestamp":1787611041603,"version":"build-2736575974"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"46","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971495, 82171759, 82101873, 82100624"],"award-info":[{"award-number":["81971495, 82171759, 82101873, 82100624"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2025,12,2]]},"DOI":"10.1038\/s41388-025-03593-9","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:57:54Z","timestamp":1760551074000},"page":"4475-4490","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["PSME3 drives Tregs infiltration and anti-PD1 resistance in hepatocellular carcinoma by regulating FBXL7\/PTEN-mediated metabolic reprogramming"],"prefix":"10.1038","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7949-4020","authenticated-orcid":false,"given":"Qiuyang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinren","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qufei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianning","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maruyama","family":"Takashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4983-5557","authenticated-orcid":false,"given":"Ling","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8931-8097","authenticated-orcid":false,"given":"Jian","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"3593_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3593_CR2","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/nrclinonc.2015.103","volume":"12","author":"JM Llovet","year":"2015","unstructured":"Llovet JM, Villanueva A, Lachenmayer A, Finn RS. Advances in targeted therapies for hepatocellular carcinoma in the genomic era. Nat Rev Clin Oncol. 2015;12:408\u201324.","journal-title":"Nat Rev Clin Oncol"},{"key":"3593_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","volume":"389","author":"J Bruix","year":"2017","unstructured":"Bruix J, Qin S, Merle P, Granito A, Huang YH, Bodoky G, et al. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;389:56\u201366.","journal-title":"Lancet"},{"key":"3593_CR4","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra1001683","volume":"365","author":"HB El-Serag","year":"2011","unstructured":"El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365:1118\u201327.","journal-title":"N Engl J Med"},{"key":"3593_CR5","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","volume":"391","author":"M Kudo","year":"2018","unstructured":"Kudo M, Finn RS, Qin S, Han KH, Ikeda K, Piscaglia F, et al. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet. 2018;391:1163\u201373.","journal-title":"Lancet"},{"key":"3593_CR6","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, et al. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. N Engl J Med. 2020;382:1894\u2013905.","journal-title":"N Engl J Med"},{"key":"3593_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01759-1","volume":"22","author":"Z Hu","year":"2023","unstructured":"Hu Z, Chen G, Zhao Y, Gao H, Li L, Yin Y, et al. Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma. Mol Cancer. 2023;22:55.","journal-title":"Mol Cancer"},{"key":"3593_CR8","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3389\/fcell.2020.00672","volume":"8","author":"Q Lei","year":"2020","unstructured":"Lei Q, Wang D, Sun K, Wang L, Zhang Y. Resistance mechanisms of anti-PD1\/PDL1 therapy in solid tumors. Front Cell Dev Biol. 2020;8:672","journal-title":"Front Cell Dev Biol"},{"key":"3593_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.coi.2021.02.001","volume":"69","author":"SA Weiss","year":"2021","unstructured":"Weiss SA, Sznol M. Resistance mechanisms to checkpoint inhibitors. Curr Opin Immunol. 2021;69:47\u201355.","journal-title":"Curr Opin Immunol"},{"key":"3593_CR10","doi-asserted-by":"publisher","first-page":"950536","DOI":"10.3389\/fimmu.2022.950536","volume":"13","author":"Y Bai","year":"2022","unstructured":"Bai Y, Chen D, Cheng C, Li Z, Chi H, Zhang Y. et al. Immunosuppressive landscape in hepatocellular carcinoma revealed by single-cell sequencing. Front Immunol. 2022;13:950536.","journal-title":"Front Immunol"},{"key":"3593_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/vaccines4030028","volume":"4","author":"B Chaudhary","year":"2016","unstructured":"Chaudhary B, Elkord E. Regulatory T cells in the tumor microenvironment and cancer progression: role and therapeutic targeting. Vaccines. 2016;4:28.","journal-title":"Vaccines"},{"key":"3593_CR12","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nm1093","volume":"10","author":"TJ Curiel","year":"2004","unstructured":"Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004;10:942\u20139.","journal-title":"Nat Med"},{"key":"3593_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","volume":"40","author":"S Kumagai","year":"2022","unstructured":"Kumagai S, Koyama S, Itahashi K, Tanegashima T, Lin YT, Togashi Y, et al. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments. Cancer Cell. 2022;40:201\u2013218.e9.","journal-title":"Cancer Cell"},{"key":"3593_CR14","doi-asserted-by":"publisher","first-page":"e002787","DOI":"10.1136\/jitc-2021-002787","volume":"9","author":"Z Wang","year":"2021","unstructured":"Wang Z, He L, Li W, Xu C, Zhang J, Wang D. et al. GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma. J Immunother Cancer. 2021;9:e002787.","journal-title":"J Immunother Cancer"},{"key":"3593_CR15","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","volume":"591","author":"MJ Watson","year":"2021","unstructured":"Watson MJ, Vignali PDA, Mullett SJ, Overacre-Delgoffe AE, Peralta RM, Grebinoski S, et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature. 2021;591:645\u201351.","journal-title":"Nature"},{"key":"3593_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.yexcr.2017.05.017","volume":"358","author":"Z Yi","year":"2017","unstructured":"Yi Z, Yang D, Liao X, Guo F, Wang Y, Wang X. PSME3 induces epithelial-mesenchymal transition with inducing the expression of CSC markers and immunosuppression in breast cancer. Exp Cell Res. 2017;358:87\u201393.","journal-title":"Exp Cell Res"},{"key":"3593_CR17","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1761205","volume":"9","author":"M Boulpicante","year":"2020","unstructured":"Boulpicante M, Darrigrand R, Pierson A, Salgues V, Rouillon M, Gaudineau B, et al. Tumors escape immunosurveillance by overexpressing the proteasome activator PSME3. Oncoimmunology. 2020;9:1761205.","journal-title":"Oncoimmunology"},{"key":"3593_CR18","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.celrep.2015.12.069","volume":"14","author":"J Sun","year":"2016","unstructured":"Sun J, Luan Y, Xiang D, Tan X, Chen H, Deng Q, et al. The 11S Proteasome subunit PSME3 is a positive feedforward regulator of NF-kappaB and important for host defense against bacterial pathogens. Cell Rep. 2016;14:737\u201349.","journal-title":"Cell Rep"},{"key":"3593_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nature08659","volume":"463","author":"MA Humbard","year":"2010","unstructured":"Humbard MA, Miranda HV, Lim JM, Krause DJ, Pritz JR, Zhou G, et al. Ubiquitin-like small archaeal modifier proteins (SAMPs) in Haloferax volcanii. Nature. 2010;463:54\u201360.","journal-title":"Nature"},{"key":"3593_CR20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453\u20137.","journal-title":"Nat Methods"},{"key":"3593_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","volume":"56","author":"PJ Heagerty","year":"2000","unstructured":"Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56:337\u201344.","journal-title":"Biometrics"},{"key":"3593_CR22","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573\u20133587.e29.","journal-title":"Cell"},{"key":"3593_CR23","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16:1289\u201396.","journal-title":"Nat Methods"},{"key":"3593_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jhep.2022.02.019","volume":"77","author":"CY Wei","year":"2022","unstructured":"Wei CY, Zhu MX, Zhang PF, Huang XY, Wan JK, Yao XZ, et al. PKCalpha\/ZFP64\/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma. J Hepatol. 2022;77:163\u201376.","journal-title":"J Hepatol"},{"key":"3593_CR25","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","volume":"78","author":"Y Liu","year":"2023","unstructured":"Liu Y, Xun Z, Ma K, Liang S, Li X, Zhou S, et al. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy. J Hepatol. 2023;78:770\u201382.","journal-title":"J Hepatol"},{"key":"3593_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg3750","volume":"7","author":"R Wu","year":"2021","unstructured":"Wu R, Guo W, Qiu X, Wang S, Sui C, Lian Q, et al. Comprehensive analysis of spatial architecture in primary liver cancer. Sci Adv. 2021;7:eabg3750.","journal-title":"Sci Adv"},{"key":"3593_CR27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2019.11.014","volume":"52","author":"AR Cillo","year":"2020","unstructured":"Cillo AR, Kurten CHL, Tabib T, Qi Z, Onkar S, Wang T, et al. Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer. Immunity. 2020;52:183\u2013199.e9.","journal-title":"Immunity"},{"key":"3593_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.canlet.2016.08.018","volume":"386","author":"J Guo","year":"2017","unstructured":"Guo J, Hao J, Jiang H, Jin J, Wu H, Jin Z. et al. Proteasome activator subunit 3 promotes pancreatic cancer growth via c-Myc-glycolysis signaling axis. Cancer Lett.2017;386:161\u20137.","journal-title":"Cancer Lett."},{"key":"3593_CR29","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1161\/CIRCULATIONAHA.117.031358","volume":"138","author":"D Sawaki","year":"2018","unstructured":"Sawaki D, Czibik G, Pini M, Ternacle J, Suffee N, Mercedes R, et al. Visceral adipose tissue drives cardiac aging through modulation of fibroblast senescence by osteopontin production. Circulation. 2018;138:809\u201322.","journal-title":"Circulation"},{"key":"3593_CR30","doi-asserted-by":"publisher","first-page":"103950","DOI":"10.1016\/j.ebiom.2022.103950","volume":"78","author":"Z Yu","year":"2022","unstructured":"Yu Z, Wei X, Liu L, Sun H, Fang T, Wang L. et al. Indirubin-3'-monoxime acts as proteasome inhibitor: therapeutic application in multiple myeloma. EBioMedicine. 2022;78:103950.","journal-title":"EBioMedicine"},{"key":"3593_CR31","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","volume":"27","author":"SL Topalian","year":"2015","unstructured":"Topalian SL, Drake CG, Pardoll DM. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell. 2015;27:450\u201361.","journal-title":"Cancer Cell"},{"key":"3593_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jhep.2021.08.029","volume":"76","author":"Y Gao","year":"2022","unstructured":"Gao Y, You M, Fu J, Tian M, Zhong X, Du C, et al. Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B. J Hepatol. 2022;76:148\u201359.","journal-title":"J Hepatol"},{"key":"3593_CR33","doi-asserted-by":"publisher","first-page":"eaba0759","DOI":"10.1126\/sciimmunol.aba0759","volume":"5","author":"JC Lee","year":"2020","unstructured":"Lee JC, Mehdizadeh S, Smith J, Young A, Mufazalov IA, Mowery CT. et al. Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis. Sci Immunol. 2020;5:eaba0759.","journal-title":"Sci Immunol"},{"key":"3593_CR34","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/hep.32419","volume":"76","author":"S Suthen","year":"2022","unstructured":"Suthen S, Lim CJ, Nguyen PHD, Dutertre CA, Lai HLH, Wasser M, et al. Hypoxia-driven immunosuppression by Treg and type-2 conventional dendritic cells in HCC. Hepatology. 2022;76:1329\u201344.","journal-title":"Hepatology"},{"key":"3593_CR35","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/s41591-022-01868-2","volume":"28","author":"AX Zhu","year":"2022","unstructured":"Zhu AX, Abbas AR, de Galarreta MR, Guan Y, Lu S, Koeppen H, et al. Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma. Nat Med. 2022;28:1599\u2013611.","journal-title":"Nat Med"},{"key":"3593_CR36","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.trecan.2022.06.008","volume":"8","author":"F Shan","year":"2022","unstructured":"Shan F, Somasundaram A, Bruno TC, Workman CJ, Vignali DAA. Therapeutic targeting of regulatory T cells in cancer. Trends Cancer. 2022;8:944\u201361.","journal-title":"Trends Cancer"},{"key":"3593_CR37","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.7150\/jca.30235","volume":"10","author":"L Yu","year":"2019","unstructured":"Yu L, Li JJ, Liang XL, Wu H, Liang Z. PSME3 promotes TGFB1 secretion by pancreatic cancer cells to induce pancreatic stellate cell proliferation. J Cancer. 2019;10:2128\u201338.","journal-title":"J Cancer"},{"key":"3593_CR38","first-page":"126525","volume":"12","author":"C Liu","year":"2019","unstructured":"Liu C, Yang J, Wu H, Li J. Downregulated miR-585-3p promotes cell growth and proliferation in colon cancer by upregulating PSME3. Onco Targets Ther. 2019;12:126525\u20136534.","journal-title":"Onco Targets Ther"},{"key":"3593_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110986","volume":"39","author":"J Gu","year":"2022","unstructured":"Gu J, Zhou J, Chen Q, Xu X, Gao J, Li X, et al. Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-beta signaling in regulatory T cells. Cell Rep. 2022;39:110986.","journal-title":"Cell Rep"},{"key":"3593_CR40","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.it.2023.06.001","volume":"44","author":"Y Wang","year":"2023","unstructured":"Wang Y, Huang T, Gu J, Lu L. Targeting the metabolism of tumor-infiltrating regulatory T cells. Trends Immunol. 2023;44:598\u2013612.","journal-title":"Trends Immunol"},{"key":"3593_CR41","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.molcel.2007.05.022","volume":"26","author":"X Chen","year":"2007","unstructured":"Chen X, Barton LF, Chi Y, Clurman BE, Roberts JM. Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. Mol Cell. 2007;26:843\u201352.","journal-title":"Mol Cell"},{"key":"3593_CR42","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add4969","volume":"9","author":"SH Son","year":"2023","unstructured":"Son SH, Kim MY, Lim YS, Jin HC, Shin JH, Yi JK, et al. SUMOylation-mediated PSME3-20S proteasomal degradation of transcription factor CP2c is crucial for cell cycle progression. Sci Adv. 2023;9:eadd4969.","journal-title":"Sci Adv"},{"key":"3593_CR43","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.cmet.2019.05.016","volume":"30","author":"Z Hu","year":"2019","unstructured":"Hu Z, Qu G, Yu X, Jiang H, Teng XL, Ding L, et al. Acylglycerol kinase maintains metabolic state and immune responses of CD8(+) T cells. Cell Metab. 2019;30:290\u2013302.e5.","journal-title":"Cell Metab"},{"key":"3593_CR44","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.molcel.2019.08.006","volume":"76","author":"X Qian","year":"2019","unstructured":"Qian X, Li X, Shi Z, Xia Y, Cai Q, Xu D, et al. PTEN suppresses glycolysis by dephosphorylating and inhibiting autophosphorylated PGK1. Mol Cell. 2019;76:516\u2013527.e7.","journal-title":"Mol Cell"},{"key":"3593_CR45","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/s41556-020-0560-6","volume":"22","author":"L Moro","year":"2020","unstructured":"Moro L, Simoneschi D, Kurz E, Arbini AA, Jang S, Guaragnella N, et al. Epigenetic silencing of the ubiquitin ligase subunit FBXL7 impairs c-SRC degradation and promotes epithelial-to-mesenchymal transition and metastasis. Nat Cell Biol. 2020;22:1130\u201342.","journal-title":"Nat Cell Biol"},{"key":"3593_CR46","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.3390\/cancers15133480","volume":"15","author":"LL Leung","year":"2023","unstructured":"Leung LL, Myles T, Morser J. Thrombin cleavage of osteopontin and the host anti-tumor immune response. Cancers. 2023;15:3480.","journal-title":"Cancers"},{"key":"3593_CR47","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.3390\/cancers12113379","volume":"12","author":"HR Moorman","year":"2020","unstructured":"Moorman HR, Poschel D, Klement JD, Lu C, Redd PS, Liu K. Osteopontin: a key regulator of tumor progression and immunomodulation. Cancers. 2020;12:3379","journal-title":"Cancers"},{"key":"3593_CR48","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1084\/jem.170.1.145","volume":"170","author":"R Patarca","year":"1989","unstructured":"Patarca R, Freeman GJ, Singh RP, Wei FY, Durfee T, Blattner F, et al. Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection. J Exp Med. 1989;170:145\u201361.","journal-title":"J Exp Med"},{"key":"3593_CR49","doi-asserted-by":"publisher","first-page":"5549","DOI":"10.1172\/JCI123360","volume":"128","author":"JD Klement","year":"2018","unstructured":"Klement JD, Paschall AV, Redd PS, Ibrahim ML, Lu C, Yang D, et al. An osteopontin\/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion. J Clin Invest. 2018;128:5549\u201360.","journal-title":"J Clin Invest"},{"key":"3593_CR50","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1136\/gutjnl-2019-318419","volume":"68","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Yang J, Xu D, Gao XM, Zhang Z, Hsu JL, et al. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade. Gut. 2019;68:1653\u201366.","journal-title":"Gut"},{"key":"3593_CR51","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/hep.24703","volume":"55","author":"S Shang","year":"2012","unstructured":"Shang S, Plymoth A, Ge S, Feng Z, Rosen HR, Sangrajrang S, et al. Identification of osteopontin as a novel marker for early hepatocellular carcinoma. Hepatology. 2012;55:483\u201390.","journal-title":"Hepatology"},{"key":"3593_CR52","doi-asserted-by":"crossref","unstructured":"Zhao, J, Jing J, Zhao W, Li X, Hou L, Zheng C et al. Osteopontin exacerbates the progression of experimental autoimmune myasthenia gravis by affecting the differentiation of T cell subsets. Int Immunopharmacol. 2020;82106335.","DOI":"10.1016\/j.intimp.2020.106335"},{"key":"3593_CR53","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/cod.12868","volume":"78","author":"LF Kraus","year":"2018","unstructured":"Kraus LF, Scheurmann N, Frenzel DF, Tasdogan A, Weiss JM. 9-cis-Retinoic acid induces a distinct regulatory dendritic cell phenotype that modulates murine delayed-type allergy. Contact Dermat. 2018;78:41\u201354.","journal-title":"Contact Dermat"},{"key":"3593_CR54","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s42255-022-00572-2","volume":"4","author":"L Geng","year":"2022","unstructured":"Geng L, Liao B, Jin L, Yu J, Zhao X, Zhao Y, et al. beta-Klotho promotes glycolysis and glucose-stimulated insulin secretion via GP130. Nat Metab. 2022;4:608\u201326.","journal-title":"Nat Metab"},{"key":"3593_CR55","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jhep.2022.03.029","volume":"77","author":"T Greuter","year":"2022","unstructured":"Greuter T, Yaqoob U, Gan C, Jalan-Sakrikar N, Kostallari E, Lu J, et al. Mechanotransduction-induced glycolysis epigenetically regulates a CXCL1-dominant angiocrine signaling program in liver sinusoidal endothelial cells in vitro and in vivo. J Hepatol. 2022;77:723\u201334.","journal-title":"J Hepatol"},{"key":"3593_CR56","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cmet.2014.12.005","volume":"21","author":"EM Palsson-McDermott","year":"2015","unstructured":"Palsson-McDermott EM, Curtis AM, Goel G, Lauterbach MA, Sheedy FJ, Gleeson LE, et al. Pyruvate kinase M2 regulates Hif-1alpha activity and IL-1beta induction and is a critical determinant of the warburg effect in LPS-activated macrophages. Cell Metab. 2015;21:65\u201380.","journal-title":"Cell Metab"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03593-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03593-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03593-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T23:02:11Z","timestamp":1762815731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03593-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":56,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2025,12,2]]}},"alternative-id":["3593"],"URL":"https:\/\/doi.org\/10.1038\/s41388-025-03593-9","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"1 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of the First Affiliated Hospital with Nanjing Medical University (2020-SRFA-329), and written informed consent was obtained from all patients in accordance with the Declaration of Helsinki. Animal experiments were approved by the Institutional Animal Care and Use Committee of Nanjing Medical University (IACUC-2006002) and performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}